[Half of the patients with primary hyperparathyroidisms have a vitamin D deficiency: aggravating the osseous attack].
Velayoudom-Cephise
Fritz-Line
FL
CHRU de Lille, clinique Marc-Linquette, service d'endocrinologie-métabolisme, 59037 Lille cedex, France. fritz-line.velayoudom@chu-guadeloupe.fr
Foucan
Lydia
L
Soudan
Benoît
B
Cardot-Bauters
Catherine
C
Vantyghem
Marie-Christine
MC
D'herbomez
Michèle
M
Tison-Muchery
Françoise
F
Wemeau
Jean-Louis
JL
D000368:Aged; D001847:Bone Diseases / Q000209:etiology*; D005260:Female; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000150:complications*; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D012720:Severity of Illness Index; D014808:Vitamin D Deficiency / Q000150:complications* / Q000453:epidemiology
La moitié des patients atteints d'hyperparathyroïdies primaires ont un déficit en vitamine D aggravant l'atteinte osseuse.